RecQL1 Antibodies

Santa Cruz Biotechnology provides a broad selection of RecQL1 monoclonal antibodies for research focused on understanding RecQL1 functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).RecQL1 is a member of the RecQ helicase family, which plays a critical role in maintaining genomic stability by unwinding DNA during replication and repair processes. RecQL1 is essential for the resolution of DNA structures that can lead to genomic instability, making it a key player in cancer research and the study of hereditary diseases. Understanding RecQL1 function can provide insights into the mechanisms of tumorigenesis and the development of therapeutic strategies. RecQL1 has been found to be overexpressed in various cancer types, suggesting its potential as a therapeutic target. Recent studies have highlighted the importance of RecQL1 in DNA damage response pathways and cell cycle regulation. Research has shown that mutations in RecQL1 can lead to increased susceptibility to certain types of cancer. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of RecQL1's role in human health and disease progression.